Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 4
1971 6
1972 6
1973 7
1974 5
1975 10
1976 7
1977 9
1978 8
1979 5
1980 8
1981 4
1982 4
1983 10
1984 10
1985 14
1986 22
1987 25
1988 17
1989 22
1990 21
1991 20
1992 12
1993 24
1994 19
1995 18
1996 15
1997 16
1998 12
1999 22
2000 17
2001 16
2002 16
2003 14
2004 14
2005 17
2006 11
2007 20
2008 19
2009 10
2010 19
2011 12
2012 12
2013 13
2014 14
2015 10
2016 12
2017 15
2018 15
2019 17
2020 24
2021 22
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

700 results
Results by year
Filters applied: . Clear all
Page 1
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine.
Smalley Rumfield C, Pellom ST, Morillon Ii YM, Schlom J, Jochems C. Smalley Rumfield C, et al. Among authors: schlom j. J Immunother Cancer. 2020 Jun;8(1):e000612. doi: 10.1136/jitc-2020-000612. J Immunother Cancer. 2020. PMID: 32554612 Free PMC article.
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
Greene S, Robbins Y, Mydlarz WK, Huynh AP, Schmitt NC, Friedman J, Horn LA, Palena C, Schlom J, Maeda DY, Zebala JA, Clavijo PE, Allen C. Greene S, et al. Among authors: schlom j. Clin Cancer Res. 2020 Mar 15;26(6):1420-1431. doi: 10.1158/1078-0432.CCR-19-2625. Epub 2019 Dec 17. Clin Cancer Res. 2020. PMID: 31848188 Free PMC article.
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies.
Strauss J, Gatti-Mays ME, Cho BC, Hill A, Salas S, McClay E, Redman JM, Sater HA, Donahue RN, Jochems C, Lamping E, Burmeister A, Marté JL, Cordes LM, Bilusic M, Karzai F, Ojalvo LS, Jehl G, Rolfe PA, Hinrichs CS, Madan RA, Schlom J, Gulley JL. Strauss J, et al. Among authors: schlom j. J Immunother Cancer. 2020 Dec;8(2):e001395. doi: 10.1136/jitc-2020-001395. J Immunother Cancer. 2020. PMID: 33323462 Free PMC article. Clinical Trial.
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors.
Strauss J, Heery CR, Schlom J, Madan RA, Cao L, Kang Z, Lamping E, Marté JL, Donahue RN, Grenga I, Cordes L, Christensen O, Mahnke L, Helwig C, Gulley JL. Strauss J, et al. Among authors: schlom j. Clin Cancer Res. 2018 Mar 15;24(6):1287-1295. doi: 10.1158/1078-0432.CCR-17-2653. Epub 2018 Jan 3. Clin Cancer Res. 2018. PMID: 29298798 Free PMC article. Clinical Trial.
Dual inhibition of TGF-β and PD-L1: a novel approach to cancer treatment.
Gulley JL, Schlom J, Barcellos-Hoff MH, Wang XJ, Seoane J, Audhuy F, Lan Y, Dussault I, Moustakas A. Gulley JL, et al. Among authors: schlom j. Mol Oncol. 2022 Jun;16(11):2117-2134. doi: 10.1002/1878-0261.13146. Epub 2022 Jan 4. Mol Oncol. 2022. PMID: 34854206 Free PMC article. Review.
700 results